COVID-19 and venous thromboembolism: part of a multisystem disease
- 1 January 2021
- journal article
- letter
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 113 (5), 390
- https://doi.org/10.17235/reed.2021.7907/2021
Abstract
We read with great interest recent scientific letters addressing abdominal aspects of COVID-19. Like Martín-Falquina IC et al. regarding the thrombotic nature of acute pancreatitis (AP) in a patient with COVID-19, our patient with AP was previously anticoagulated. The association in the medical literature between viral infections (such as those caused by the human immunodeficiency viruses, hepatitis C and influenza) and venous thromboembolism (VTE) has again become evidence in the scientific community whether in 2017 in the epidemic of Chicungunya and Zika or more recently in the current COVID-19 pandemic.Keywords
This publication has 4 references indexed in Scilit:
- The versatile heparin in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJournal of the American College of Cardiology, 2020
- Pancreatic injury in COVID-19: pathogenesis and challengesRevista Española de Enfermedades Digestivas, 2020
- SARS-CoV-2 and acute pancreatitis: a new etiological agent?Revista Española de Enfermedades Digestivas, 2020